Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 6341 record(s)

Req # A-2023-001205

Adverse Drug Reactions (ADRs) for Ondansetron. Report numbers: E2B_06666868, E2B_06659902, E2B_06697588, E2B_06702227, E2B_06662559,E2B_06707974. ADR for Dexilant. Report number: 001069005. ADR for Entyvio. Report number: E2B_06698466. ADR for Vedolizumab. Report number: 001059855. ADR for Ixazomib. Report number: E2B_06651889.

Organization: Health Canada

1174 page(s)
April 2024

Req # A-2023-001232

Adverse Drug Reactions (ADRs). Report numbers: 001063643, E2B_06694721, E2B_06676239.

Organization: Health Canada

2079 page(s)
April 2024

Req # A-2023-001247

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-110762-550.

Organization: Health Canada

5 page(s)
April 2024

Req # A-2023-001250

Adverse Drug Reactions (ADRs). Report numbers: 001038521, 001041193, E2B_06401905, 001038909, E2B_06356700, E2B_06336965, 001037598.

Organization: Health Canada

71 page(s)
April 2024

Req # A-2023-001304

Adverse Drug Reaction (ADR). Report number: E2B_06659476.

Organization: Health Canada

8 page(s)
April 2024

Req # A-2023-001355

Adverse Drug Reactions (ADRs). Report numbers: E2B_06755516, E2B_06730133, 001071489, 001067986, E2B_06765443, E2B_06763453, E2B_06723246.

Organization: Health Canada

73 page(s)
April 2024

Req # A-2023-001375

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-100467-576.

Organization: Health Canada

24 page(s)
April 2024

Req # A-2023-001377

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-108924-437.

Organization: Health Canada

46 page(s)
April 2024

Req # A-2023-001381

Adverse Drug Reactions (ADRs). Report numbers: 001012966, E2B_05157140, E2B_05138899, 001047993, E2B_06602737, E2B_06592266, E2B_04713322, E2B_05668332, E2B_06602443, 000913889.

Organization: Health Canada

150 page(s)
April 2024

Req # A-2023-001400

Adverse Drug Reactions (ADRs). Report numbers: 001063898, E2B_06783807.

Organization: Health Canada

19 page(s)
April 2024
Date modified: